Tag: life sciences
-
Algorithm Quickly Customizes Walking Exoskeleton
Researchers at Carnegie Mellon University in Pittsburgh wrote and tested an algorithm for exoskeletons that customize the devices to a person’s walking pattern in about an hour.
-
Long-Acting Drug Blocks Opioid Effects, Withdrawal
Findings from a clinical trial show a formulation of the drug buprenorphine given once a week blocks effects of subsequent opioid exposure and withdrawal symptoms.
-
Computer-Designed Antibodies Target Alzheimer’s Proteins
Researchers in Europe designed antibodies, like those in the immune system, to attack protein deposits in the brain associated with Alzheimer’s disease.
-
Commercial-Scale Flu Vaccine Produced in Cell Cultures
A vaccine developer says it produced large quantities of a current influenza vaccine for distribution to clinics and hospitals, grown in animal cell cultures rather than eggs.
-
Organ Chips to be Studied on Space Station
A range of biological functions will be assessed with model organs on plastic chips in a series of experiments on the International Space Station.
-
FDA Approves Skin Infection Drug
The U.S. Food and Drug Administration approved a new drug that treats serious bacterial skin infections, including those often resistant to current antibiotics.
-
Engineered Algae Doubles Bio-Oil Content
An industry biotechnology team created a genetically-engineered variety of algae that doubles its oil content without limiting its ability to grow.
-
FDA Developing Digital Device Certification Process
The U.S. Food and Drug Administration expects to unveil a new procedure for certifying digital medical devices that the agency says should speed their entry to the market.
-
Cancer Drug Produced in Small Continuous-Flow Batches
A team from drug maker Eli Lilly & Company devised techniques for producing an experimental cancer drug in small quantities but with safe, economical methods used in continuous flow manufacturing.
-
Coalition to Make 10,000 Open-Access Synthetic Genes
A company with a process for creating synthetic DNA and a foundation promoting open access to biotechnology agreed to produce 10,000 synthetic genes made available at no cost to researchers.